Willingness to use pre-exposure prophylaxis for HIV prevention among female sex workers: a cross-sectional study in China

被引:23
作者
Peng, Bin [1 ,2 ]
Yang, Xiaowei [2 ]
Zhang, Yan [1 ]
Dai, Jianghong [3 ]
Liang, Hao [4 ]
Zou, Yunfeng [4 ]
Luo, Jinkun [5 ]
Peng, Hongbin [5 ]
Zhong, Xiaoni [1 ]
Huang, Ailong [6 ]
机构
[1] Chongqing Med Univ, Sch Publ Hlth, Chongqing, Peoples R China
[2] Univ Calif Davis, Sch Med, Div Biostat, Davis, CA USA
[3] Xinjiang Med Univ, Sch Publ Hlth, Xinjiang, Peoples R China
[4] Guangxi Med Univ, Sch Publ Hlth, Nanning, Peoples R China
[5] Shunqing Ctr Dis Control & Prevent, Nanchong, Sichuan, Peoples R China
[6] Chongqing Med Univ, Virus Hepatitis Res Inst, Chongqing, Peoples R China
来源
HIV AIDS-RESEARCH AND PALLIATIVE CARE | 2012年 / 4卷
关键词
human immunodeficiency virus; infection; pre-exposure prophylaxis; PrEP willingness; female sex workers;
D O I
10.2147/HIV.S33445
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Pre-exposure prophylaxis (PrEP) is a strategy developed to prevent individuals who are human immunodeficiency virus (HIV)-negative from developing HIV infection. In China, while conducting a clinical trial to investigate the effectiveness and safety of PrEP, we performed this survey to assess the willingness of female sex workers to use PrEP, and identify predictors of this willingness. Methods: From July 2009 to April 2010, a cross-sectional study was carried out in four provinces of China. We recruited 1611 female sex workers who completed a self-administered survey to assess their awareness of and intention to use PrEP. The survey also canvassed demographic, behavioral, and psychosocial variables. Bivariate and multivariable logistic regression models were fitted to identify predictors of intent to use PrEP. Results: In total, 69% of the women (95% confidence interval [CI] 66.7-71.3) reported intent to use PrEP, and 12% (95% CI 10.5-13.7) had used drugs in the past to prevent a sexually transmitted infection. Further, 16.5% (95% CI 14.7-18.4) had previously heard of PrEP, and 1.4% (95% CI 0.9-2.1) had used PrEP previously to prevent HIV infection. Multivariate analysis indicated the following significant predictors of intent to use PrEP: Han ethnicity (adjusted odds ratio [AOR] 1.446; P = 0.011), urban residence (AOR 1.302; P = 0.027), knowledge about transmission of HIV/acquired immune deficiency virus syndrome (AIDS, AOR 1.817; P = 0.0007), a history of sexually transmitted infection (AOR 1.830; P < 0.0001), a history of using medication to prevent a sexually transmitted disease (AOR 2.547; P < 0.0001), and willingness to access knowledge about HIV/AIDS (AOR 2.153; P < 0.0001). Conclusion: The majority of female sex workers reported intent to use PrEP if it is safe and effective. Given that most of the participants had never heard of PrEP before, we strongly recommend that educational materials be developed with detailed introduction of PrEP. The risks and benefits of PrEP use should be fully explained to potential users when promoting PrEP in the future.
引用
收藏
页码:149 / 158
页数:10
相关论文
共 33 条
  • [1] Potential Impact of Antiretroviral Chemoprophylaxis on HIV-1 Transmission in Resource-Limited Settings
    Abbas, Ume L.
    Anderson, Roy M.
    Mellors, John W.
    [J]. PLOS ONE, 2007, 2 (09):
  • [2] AVAC, GLOB ADV AIDS PREV P
  • [3] Clauson Kevin A., 2009, Pharmacy Pract (Granada), V7, P11
  • [4] HIV/AIDS At Last, Vaginal Gel Scores Victory Against HIV
    Cohen, Jon
    [J]. SCIENCE, 2010, 329 (5990) : 374 - 375
  • [5] Cunningham W, 2008, INT AIDS SOC C AUG 3
  • [6] Criteria for drugs used in pre-exposure prophylaxis trials against HIV infection
    Derdelinckx, Inge
    Wainberg, Mark A.
    Lange, Joep M. A.
    Hill, Andrew
    Halima, Yasmin
    Boucher, Charles A. B.
    [J]. PLOS MEDICINE, 2006, 3 (11) : 1999 - 2004
  • [7] Risk compensation in HIV prevention: Implications for vaccines, microbicides, and other biomedical HIV prevention technologies
    Eaton L.A.
    Kalichman S.C.
    [J]. Current HIV/AIDS Reports, 2007, 4 (4) : 165 - 172
  • [8] Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir
    Garcia-Lerma, J. Gerardo
    Otten, Ron A.
    Qari, Shoukat H.
    Jackson, Eddie
    Cong, Mian-er
    Masciotra, Silvina
    Luo, Wei
    Kim, Caryn
    Adams, Debra R.
    Monsour, Michael
    Lipscomb, Jonathan
    Johnson, Jeffrey A.
    Delinsky, David
    Schinazi, Raymond F.
    Janssen, Robert
    Folks, Thomas M.
    Heneine, Walid
    [J]. PLOS MEDICINE, 2008, 5 (02) : 291 - 299
  • [9] Oral pre-exposure prophylaxis for HIV prevention
    Garcia-Lerma, J. Gerardo
    Paxton, Lynn
    Kilmarx, Peter H.
    Heneine, Walid
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2010, 31 (02) : 74 - 81
  • [10] Gill B, DEMOGRAPHY HIV AIDS